Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

✍ Scribed by Nash, Richard; Hutton, George J.; Racke, Michael; Popat, Uday; Devine, Steven M.; Georges, George; Griffith, Linda; Muraro, Paolo A.; Openshaw, Harry; Sayre, Peter; Stuve, Olaf; Arnold, Douglas; Spychala, Meagan; Lim, Noha; Malhotra, Sachin; Phippard, Deborah; Wundes, Annette; Kraft, George H.; Bowen, James D.

• Book ID: 122384170
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 62 KB
• Volume: 19
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2012.11.062